New Combined ASOP EU and EAASM Newsletter 2025
A new combined newsletter comprising the combined activities is published
To read the report, click here
EVENT: Save the date 12th February 2024 “The EU Pharmaceuticals – why should online access to prescription medicines be allowed?”
12th February 2024 1500-1700CET Radisson Red Brussels
Find out more
The Urgent Need to Reduce Medication Errors in Hospitals to Prevent Patient and Second Victim Harm
PRESS RELEASE: “The Urgent Need to Reduce Medication Errors in Hospitals to Prevent Patient and Second Victim Harm”
To read the press release, click here
EU Nanomedicines Coalition
In order to ensure their safety and efficacy, it is essential that a robust regulatory process exists and that all stakeholders are fully aware of their complexities.
To view the report, click here
On 7 April 2021, the EAASM published its report ‘Patient Safety and the Implementation of the Falsified Medicines Directive in the Hospital Environment: Practical solutions and benefits’.
PRESS RELEASE: New report clearly demonstrates that implementing the Falsified Medicines Directive in hospitals brings about massive positive change
To read the report, click here
European Collaborative Action on Medication Errors and Traceability
The European Collaborative Action on Medication Errors and Traceability (ECAMET) is a patient safety initiative developed by a group of health professionals and stakeholders.
Visit ECAMET
New report ‘Patient Safety and Nanomedicines: the need for a centralised regulatory procedure’ calls to ensure patient safety through regulatory clarity
To read the report, click here
New scientific paper
Patient safety issues associated with the use of compounded medicines as alternatives to approved pharmaceutical products in Europe and how best practice can improve outcomes
Find out more
Google
ASOP EU AdWords Educational campaign now running in 5 major European countries
Find out more

Pagina Iniziale

‘Alleanza europea per l’accesso a medicinali sicuri (EAASM, European Alliance for Access to Safe Medicines) è una piattaforma indipendente e intersettoriale che si batte per impedire la commercializzazione di medicinali contraffatti e di bassa qualità al fine di garantire una maggiore sicurezza dei pazienti. La diffusione dell’informazione pubblica relativa alle questioni dei medicinali contraffatti è una delle attività principali dell’EAASM.

Su questo sito Web sono disponibili numerose informazioni sui farmaci contraffatti e di bassa qualità. Nella sezione Consigli sono riportati dei suggerimenti per verificare l’autenticità dei medicinali acquistati con prescrizione medica obbligatoria. Nella sezione Notizie è possibile leggere le ultime notizie sui farmaci contraffatti in Europa e nel mondo, nonché consultare gli aggiornamenti sulle attività dell’EAASM. L’EAASM aggiorna regolarmente il sito Web e vi aggiunge risorse utili in modo che gli utenti abbiano a disposizione il maggior numero di informazioni possibile su come ottenere medicinali sicuri.

Per ulteriori informazioni o in caso di domande inviare un messaggio di posta elettronica all’indirizzo enquiries@109.70.148.65.

EAASM Newsletters

Summer 2025
Summer Newsletter 2025
Di più

Notizie (in inglese)

Articles from March 2010

1 Marzo 2010

Staffordshire woman sentenced for the supply of counterfeit drugs The Medicines and Healthcare products Regulatory Agency (MHRA) and Staffordshire Police have investigated, since January 2008,

Read More ›

Articles from February 2010

1 Febbraio 2010

POST issues counterfeit report following Pfizer’s study The UK Parliamentary Office of Science and Technology (POST) has compiled a counterfeit report following a study commissioned

Read More ›

Articles from January 2010

1 Gennaio 2010

FDA warns of bogus agents duping public Consumers buying medicines over the Internet are already risking exposure to fake medicines, but are also being preyed

Read More ›

View more articles ›